Spiral Therapeutics Raises $27M Series B

Spiral Therapeutics has successfully closed a $27 million Series B financing round, attracting new strategic investors including Advanced Bionics and a major global pharmaceutical company. Gund Investment led the round, underscoring confidence in Spiral's innovative approach. This significant funding will accelerate the development of Spiral's therapeutic pipeline and support its strategic initiatives. The partnership with Advanced Bionics further strengthens Spiral's position and provides valuable resources for advancing its mission in the biotechnology sector.